2
Announcements
Trials
Browse
Landscape
Phase
Phase 4
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Gastrointestinal
1
Conditions
Multiple Myeloma
237
Precursor Cell Lymphoblastic Leukemia-Lymphoma
69
Recurrence
36
Burkitt Lymphoma
34
Leukemia
32
Lymphoma
30
Neoplasms, Plasma Cell
22
Lymphoma, Non-Hodgkin
19
Immunoglobulin Light-chain Amyloidosis
18
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma
17
Lymphoma, Mantle-Cell
16
Neoplasms
15
Nausea
15
Lymphoma, Large B-Cell, Diffuse
15
Vomiting
14
Hodgkin Disease
13
Breast Neoplasms
12
Waldenstrom Macroglobulinemia
11
Leukemia, Biphenotypic, Acute
11
Lymphoma, Follicular
10
Lymphoma, B-Cell, Marginal Zone
10
Amyloidosis
10
Lung Neoplasms
9
Smoldering Multiple Myeloma
8
Prostatic Neoplasms
8
Neoplasm Metastasis
8
Leukemia, Myeloid, Acute
8
Hematologic Neoplasms
7
Blast Crisis
7
Lymphoma, T-Cell, Cutaneous
6
Interventions
Oxaliplatin
6
Irinotecan
5
Fluorouracil
5
Drug Therapy
4
Bevacizumab
4
Magnetic Resonance Spectroscopy
3
Leucovorin
3
Capecitabine
3
5,10-methylenetetrahydrofolic acid
3
pembrolizumab
2
Ocoxin
2
Levoleucovorin
2
Folfox protocol
2
Exercise Test
2
Cyclophosphamide
2
Cetuximab
2
trifluridine tipiracil drug combination
1
sintilimab
1
repotrectinib
1
pralsetinib
1
penpulimab
1
napabucasin
1
lutetium Lu 177 dotatate
1
huachansu
1
guadecitabine
1
golotimod
1
encorafenib
1
copper dotatate CU-64
1
alectinib
1
XELOX
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Gastrointestinal Diseases
×
Calcium Dobesilate
×
Clear all
NCT03723447
2021-02-17
TINGLE
Cedars-Sinai Medical Center
Phase 4
Completed
102 enrolled
9 charts